PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,140 | -6.4% | 1,015 | +22.3% | 0.00% | – |
| Q2 2023 | $33,258 | +6.5% | 830 | +8.5% | 0.00% | – |
| Q1 2023 | $31,220 | -8.6% | 765 | -13.6% | 0.00% | -100.0% |
| Q4 2022 | $34,170 | -31.7% | 885 | -5.3% | 0.00% | 0.0% |
| Q3 2022 | $50,000 | -9.1% | 935 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $55,000 | -22.5% | 935 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $71,000 | +26.8% | 935 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $56,000 | -9.7% | 935 | -15.8% | 0.00% | 0.0% |
| Q3 2021 | $62,000 | -7.5% | 1,110 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $67,000 | -100.0% | 1,110 | -58.0% | 0.00% | -50.0% |
| Q1 2021 | $185,038,000 | +246617.3% | 2,640 | +112.0% | 0.00% | 0.0% |
| Q4 2020 | $75,000 | -5.1% | 1,245 | -5.0% | 0.00% | 0.0% |
| Q3 2020 | $79,000 | +16.2% | 1,310 | +0.4% | 0.00% | 0.0% |
| Q2 2020 | $68,000 | +44.7% | 1,305 | -7.1% | 0.00% | 0.0% |
| Q1 2020 | $47,000 | -46.0% | 1,404 | -27.6% | 0.00% | -33.3% |
| Q4 2019 | $87,000 | +13.0% | 1,939 | -4.4% | 0.00% | 0.0% |
| Q3 2019 | $77,000 | +8.5% | 2,029 | +23.0% | 0.00% | 0.0% |
| Q2 2019 | $71,000 | – | 1,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |